After 30 years within the biopharmaceutical industry, Andy recently established his own consultancy business advising clients such as AstraZeneca and CBC Ltd in the areas of strategy, policy development and engagement.
In his previous role at AstraZeneca, Andy oversaw the move and integration of the organization into the Cambridge area ahead of their move onto the Cambridge Biomedical Campus. As part of that role, he was an active contributor to evolving Cambridge’s thinking in areas like transport, skill development, community amenity, housing and digital.
Andy remains active in the business community. He sits on the board of Cambridge Network, the CPCA business board, is the business representative on the Greater Cambridge Partnership Executive board, a Councillor of the CBI Regional Council and Thriving Nations National Committee.